Navigation Links
Dr. Julian Henley MD Presents 'BioMatrix Lift'
Date:11/2/2009

NEW HAVEN, Conn., Nov. 2 /PRNewswire/ -- Renowned plastic surgeon Dr. Julian Henley will be taking consultations in New York City, Darien, CT and New Haven, CT for potential candidates of his revolutionary new procedure the BioMatrix Lift.

For over 20 years, Dr. Henley has stood at the forefront of his field's exciting evolution, developing new techniques to improve results and expand possibilities. The culmination of two years of research, the BioMatrix Lift represents the latest in surgical facial rejuvenation procedures designed to provide a healthier and more youthful appearance.

"The BioMatrix Lift uses established techniques combined with a biological matrix that regenerates tissue in areas where tissue is deficient," explains Dr. Henley. "It allows us to improve areas surgeons have previously been unable to improve, especially around the eyes, the orbit and eye socket."

Facelifts have traditionally been a tightening operation or a repositioning operation where if something is hanging you lift it up. But a youthful appearance depends on a certain degree of pliancy and fullness; if you tighten skin and remove wrinkles you can have an older looking face.

As a result, many non-surgical physicians, like dermatologists, have advocated non-surgical facelifts, which increase volume through injectibles to achieve desired results.

"What I'm proposing is not that one specialty is right or the other is wrong," says Dr. Henley, "because when you combine these approaches you can achieve even more remarkable results. The BioMatrix Lift allows us to improve the aesthetic benefits of the procedure by stimulating the patient's own tissue regeneration."

The biological matrix employed by Dr. Henley is derived from natural materials. All the cells are removed but its growth factors remain preserved; these growth factors provide the structure to facilitate the rebuilding of normal tissue. While this technology has already been used to repair hearts, diaphragms and hernia, Dr. Henley is the first to use it for cosmetic applications.

"Medicine is competitive but it's also collaborative science," says Dr. Henley. "The BioMatrix Lift is a new technology I hope will be adopted over time by other practitioners, for whom it will give a greater benefit to their patients."

Dr. Julian Henley visit http://www.drhenley.com.

    Contact Info

    Dr. Julian Henley
    Aesthetic Plastic Surgery Center
    1423 Chapel St.
    New Haven, CT 06511
    Contact: Dr. Julian Henley
    Tel: (203) 787-4647

    Close-Up TV News, (631) 421-6072

SOURCE Dr. Julian Henley


'/>"/>
SOURCE Dr. Julian Henley
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
3. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
8. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
11. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):